Nuwellis, Inc. (NASDAQ:NUWE) Short Interest Update

Nuwellis, Inc. (NASDAQ:NUWE) saw a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 25,457 shares, a drop of 93.1% from the January 29th total of 370,965 shares. Based on an average daily volume of 206,373 shares, the short-interest ratio is presently 0.1 days. Currently, 1.7% of the company’s shares are sold short. Currently, 1.7% of the company’s shares are sold short. Based on an average daily volume of 206,373 shares, the short-interest ratio is presently 0.1 days.

Institutional Investors Weigh In On Nuwellis

An institutional investor recently raised its position in Nuwellis stock. Sabby Management LLC lifted its position in shares of Nuwellis, Inc. (NASDAQ:NUWE) by 149.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 89,685 shares of the company’s stock after purchasing an additional 53,791 shares during the quarter. Nuwellis comprises approximately 0.2% of Sabby Management LLC’s holdings, making the stock its 18th largest holding. Sabby Management LLC owned approximately 4.80% of Nuwellis worth $156,000 at the end of the most recent quarter. Institutional investors own 3.13% of the company’s stock.

Wall Street Analysts Forecast Growth

NUWE has been the topic of several recent analyst reports. Wall Street Zen downgraded shares of Nuwellis from a “hold” rating to a “sell” rating in a research note on Saturday, November 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Nuwellis in a research note on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Nuwellis Price Performance

NUWE stock traded up $0.05 on Wednesday, hitting $1.66. 61,734 shares of the company were exchanged, compared to its average volume of 358,404. The stock has a market capitalization of $3.10 million, a price-to-earnings ratio of -0.02 and a beta of -0.11. Nuwellis has a twelve month low of $1.60 and a twelve month high of $56.28. The business’s fifty day moving average is $2.26 and its two-hundred day moving average is $3.11.

About Nuwellis

Nuwellis (NASDAQ:NUWE) is a medical technology company focused on developing therapies and devices to manage fluid overload in patients with cardiorenal and cardiovascular conditions. The company’s core business revolves around designing, manufacturing and marketing the Aquadex™ FlexFlow® System, a gentle ultrafiltration device intended to remove excess fluid in patients with acute decompensated heart failure, cardiorenal syndrome and other fluid‐overload disorders. By providing an alternative to traditional diuretic therapy, Nuwellis aims to improve patient outcomes and reduce hospital stays.

The Aquadex FlexFlow System operates by drawing blood through a low‐shear filter and returning it to the patient, allowing precise control of fluid removal at the bedside outside of an intensive care setting.